These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38742545)

  • 41. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials.
    Wang L; Peng P; Zhang O; Xu X; Yang S; Zhao Y; Zhou Y
    PLoS One; 2014; 9(12):e113352. PubMed ID: 25473831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determinants and Prognostic Significance of Periprocedural Myocardial Injury in Patients With Successful Percutaneous Chronic Total Occlusion Interventions.
    Lee SW; Lee PH; Kang SH; Choi H; Chang M; Roh JH; Yoon SH; Ahn JM; Park DW; Kang SJ; Kim YH; Lee CW; Park SW; Park SJ
    JACC Cardiovasc Interv; 2016 Nov; 9(21):2220-2228. PubMed ID: 27832848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coronary artery calcium score in predicting periprocedural myocardial infarction in patients undergoing an elective percutaneous coronary intervention.
    Kang MG; Kang Y; Jang HG; Kim K; Koh JS; Park JR; Hwang SJ; Hwang JY; Bae JS; Ahn JH; Jang JY; Park Y; Jeong YH; Kwak CH; Park HW
    Coron Artery Dis; 2018 Nov; 29(7):589-596. PubMed ID: 29965838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
    Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
    JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of periprocedural myocardial infarction on mortality in older adults with non-ST-segment elevation acute coronary syndrome: a pooled analysis of the FRASER and HULK studies.
    Erriquez A; Pavasini R; Biscaglia S; Tebaldi M; Tonet E; Maietti E; Cimaglia P; Grazzi G; Scoccia A; Cardelli LS; Verardi FM; Morelli C; Campana R; Rubboli A; Mazzoni G; Volpato S; Ferrari R; Campo G
    J Cardiovasc Med (Hagerstown); 2021 Jul; 22(7):546-552. PubMed ID: 34076602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition).
    Cavender MA; Bhatt DL; Stone GW; White HD; Steg PG; Gibson CM; Hamm CW; Price MJ; Leonardi S; Prats J; Deliargyris EN; Mahaffey KW; Harrington RA;
    Circulation; 2016 Sep; 134(10):723-33. PubMed ID: 27482008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic Significance of Peri-procedural Myocardial Infarction in the Era of High Sensitivity Troponin: A Validation of the Joint ACCF/AHA/ESC/WHF Universal Definition of Type 4a Myocardial Infarction with High Sensitivity Troponin T.
    Liou K; Jepson N; Kellar P; Ng B; Isbister J; Giles R; Friedman D; Allan R; Lau A; Pitney M; Ooi SY
    Heart Lung Circ; 2015 Jul; 24(7):673-81. PubMed ID: 25697382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Post-procedural elevated cardiac troponin I and the association with 5-year mortality in patients undergoing elective PCI.
    Sun Q; Zhu P; Xu J; Jiang L; Chen Y; Zhao X; Song L; Yang Y; Gao R; Xu B; Yuan J; Song Y
    Heliyon; 2024 Apr; 10(7):e27979. PubMed ID: 38596066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
    Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B
    Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjunctive loading dose of cilostazol in preventing periprocedural myocardial infarction.
    Xu LX; Chen KY; Liu T; Zheng XT; Jiao ZQ; Xu Y; Li G
    Cardiovasc Ther; 2016 Aug; 34(4):225-33. PubMed ID: 27133311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in East Asian patients undergoing percutaneous coronary intervention: A meta-analysis of fifteen randomized controlled trials.
    Liu J; Zhang B; Chen M; Zheng B
    Medicine (Baltimore); 2021 Jun; 100(25):e26278. PubMed ID: 34160392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of Periprocedural Myocardial Infarction on 10-Year Mortality After Coronary Stent Implantation in Patients With Diabetes Mellitus.
    Katoh H; Ohya M; Kadota K
    Am J Cardiol; 2022 Sep; 178():3-10. PubMed ID: 35794056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention.
    Negro F; Verdoia M; Nardin M; Suryapranata H; Kedhi E; Dudek D; De Luca G;
    J Atheroscler Thromb; 2021 Feb; 28(2):137-145. PubMed ID: 33342966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of periprocedural biomarker elevation on mortality in stable angina pectoris patients undergoing elective coronary intervention: a systematic review and meta-analysis including 24 666 patients.
    Soud M; Hideo-Kajita A; Ho G; Yacob O; Alahdab F; King F; Waksman R; McFadden EP; Garcia-Garcia HM
    Coron Artery Dis; 2020 Mar; 31(2):137-146. PubMed ID: 31609755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of Periprocedural Myocardial Injury on Long-Term Outcomes After Percutaneous Coronary Intervention Requiring Atherectomy.
    Emori H; Shiono Y; Kuriyama N; Honda Y; Kadooka K; Kudo T; Ogata K; Kimura T; Nishihira K; Tanaka A; Shibata Y
    Am J Cardiol; 2024 Jul; 222():1-7. PubMed ID: 38677665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Bulluck H; Paradies V; Barbato E; Baumbach A; Bøtker HE; Capodanno D; De Caterina R; Cavallini C; Davidson SM; Feldman DN; Ferdinandy P; Gili S; Gyöngyösi M; Kunadian V; Ooi SY; Madonna R; Marber M; Mehran R; Ndrepepa G; Perrino C; Schüpke S; Silvain J; Sluijter JPG; Tarantini G; Toth GG; Van Laake LW; von Birgelen C; Zeitouni M; Jaffe AS; Thygesen K; Hausenloy DJ
    Eur Heart J; 2021 Jul; 42(27):2630-2642. PubMed ID: 34059914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent.
    Ishibashi Y; Muramatsu T; Nakatani S; Sotomi Y; Suwannasom P; Grundeken MJ; Cho YK; Garcia-Garcia HM; van Boven AJ; Piek JJ; Sabaté M; Helqvist S; Baumbach A; McClean D; de Sousa Almeida M; Wasungu L; Miquel-Hebert K; Dudek D; Chevalier B; Onuma Y; Serruys PW
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1053-1063. PubMed ID: 26205444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.